VIVANZA

This brand name is authorized in Austria, Estonia, Spain, Ireland, Lithuania, Poland

Active ingredients

The drug VIVANZA contains one active pharmaceutical ingredient (API):

1 Vardenafil UNII 5M8S2CU0TS - VARDENAFIL HYDROCHLORIDE

Vardenafil is a potent and selective inhibitor of the cGMP specific phosphodiesterase type 5 (PDE5), the most prominent PDE in the human corpus cavernosum. Vardenafil is an oral therapy for the improvement of erectile function in men with erectile dysfunction. In the natural setting, i.e. with sexual stimulation it restores impaired erectile function by increasing blood flow to the penis. Read about Vardenafil

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VIVANZA Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04BE09	Vardenafil	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction
Discover more medicines within G04BE09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1196399, 1196401, 1196412, 1196423, 1196434, 1196445, 1196456, 1196467, 1196478, 1196489, 1196490, 1196502, 1547355, 1547366, 1547377, 1619377
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 123249009
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1031185, 1031186, 1031187, 1031188, 1031189, 1031190, 1031191, 1031192, 1031193, 1031194, 1031195, 1031196, 1063721, 1063722, 1063723, 1071084
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100127230, 100127246, 100127252, 100313598